https://www.selleckchem.com/products/gw0742.html
Patients who achieved remission had infliximab serum levels between 4.26-8.26 ug/ml versus 0.06-1.43 ug/ml in patients who did not achieve remission after induction. Infliximab serum levels were 2.84-7.75 ug/ml and 0.05-2.69 ug/ml in patients who achieved remission versus those who did not achieve remission after six months of treatment. Overall, 4.26-8.26 ug/ml was found to be the best cut-off range for remission. in our clinical practice, serum levels of infliximab in Crohn's disease patients should be higher than 4 ug/ml to achieve cl
Like
Comment
Share
